Simplify Logo

Full-Time

Director – Isotope Supply

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Expert

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Management
Quality Assurance (QA)
Requirements
  • BSc degree in engineering or related field or equivalent relevant experience required
  • 10+ years of operations leadership of US/EMEA cGMP manufacturing operations required
  • API and sterile drug product experience is preferred
  • Experience with major investment projects, along with new supplier/plant qualifications and start-ups
  • Prior experience in engineering and process design of chemical or isotope process and facilities according to Lean concepts in material, people, and waste flows, preferably in aseptic manufacturing or radiopharmaceutical processing environments
  • Direct involvement with quality regulatory inspections of facilities from major agencies such as FDA, TGA, or EMA
  • Understanding of Radiation Safety regulations in the markets where Telix has Operations such as (US, AUS, and EMEA)
  • Significant Environment Health and Safety, and GxP / QA experience building an injury and error-free culture with knowledge of multiple compliance areas (corporate governance, financial, quality, environment, safety)
Responsibilities
  • Own sourcing and manufacturing of precursor isotopes and irradiation services, focusing on stabilized isotope supply for 10+ years
  • Act as the leader to interface and collaborate with the matrix product development and commercial management teams for isotope supplies
  • Identify and evaluate new potential suppliers or alliances in conjunction with the Isotope Centre of Excellence (ICE) team
  • Oversee manufacturing of isotopes at existing and future Telix locations, as well as the external isotope suppliers
  • Establish supply management plans and initiatives to enhance, accelerate, and grow Telix’s pipeline of products; acting as a subject matter expert (SME) for isotopes and isotopes supplies during program reviews, evaluations, and strategic decisions
  • Develop and manage the isotope supply budget. Identify opportunities for cost savings and efficiency improvements while maintaining high supply standards
  • Lead long-term planning initiatives to identify and mitigate risks related to isotope supply. Analyze market trends, forecast demands, and develop contingency plans to address potential disruptions
  • Develop and implement crisis management plans to address emergencies and supply chain disruptions. Lead response efforts to ensure minimal impact on operations
  • Responsible to author, review and/or approve regulatory filing sections related to isotopes
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases using targeted radiation. Their products work by delivering precise radiation to affected areas, which helps in making better treatment decisions and providing personalized therapy. Unlike many other biopharmaceutical companies, Telix focuses specifically on areas such as urologic oncology, neuro-oncology, musculoskeletal oncology, and bone marrow conditioning, addressing significant unmet medical needs. The company's goal is to enhance patient care while maintaining ethical practices and environmental responsibility, ensuring that they create sustainable value for patients, shareholders, and employees.

Company Stage

Grant

Total Funding

$63.5M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

12%

1 year growth

27%

2 year growth

90%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.